Priority Date: 28.02.11 (US 201113037171)

IMMUNOLOGICALLY MODIFIED CARBON NANOTUBES FOR CANCER TREATMENT

  • Application ID: EP12752621
  • Status: GRANT OF PATENT INTENDED

Attorney

no operation time available
1 office
active in Legal Services

Specialization

This patent has the IPC combination A61, B82, and C12 is specialized in the combination A61, B82, and C12. We found, that TransMIT GmbH, Pons Patentes y Marcas Internacional S.L., Novitas Patent AB are specialized in all of these IPC classes. For a similar patent, they might be a good choice.

Timeline

  • 28.02.2011 - Priority Date (US 201113037171)
  • 07.09.2012 - Publication A2 (WO2012118857)
  • 08.01.2014 - Publication A2 (EP2680919)